Zenotech Laboratories Ltd

NSE: BSE: 532039

₹44.50

(0.38%)

Sun, 13 Sept 2026, 05:20 am

MTF 5xInvest in Zenotech Laboratories Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)274.52

PE Ratio0

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Zenotech Laboratories News

Zenotech Labs Q1FY26: Revenue rises 11%, loss narrows

Zenotech Laboratories reported Q1FY26 standalone revenue of ₹959.64 lakh, up 11% YoY. Net loss narrowed to ₹45.55 lakh from ₹98.96 lakh a year ago, driven by higher operating income.

28 Jul 2026

companies

Zenotech Labs clarifies no material info withheld

Zenotech Laboratories responds to BSE query on price movement, confirms compliance with disclosure norms and states no material information has been withheld that could impact stock price.

10 Apr 2026

companies

Zenotech Labs Files Q4FY26 Compliance Certificate

Zenotech Laboratories Limited submitted its quarterly compliance certificate under SEBI regulations for the quarter ended March 31, 2026, confirming proper dematerialization processes.

07 Apr 2026

companies

Zenotech Labs Appoints Independent Director

Zenotech Laboratories successfully appointed Mr. Nikkhil Venilal Kothhari as Independent Director through postal ballot with 99.90% approval from shareholders on March 11, 2026.

12 Mar 2026

stocks

Zenotech Labs Q3FY26 Results & Board Changes

Zenotech Laboratories reports Q3FY26 net profit of ₹192.56 lakhs, appoints new independent director, and reconstitutes board committees following completion of director's tenure.

23 Jan 2026

co actions results

Showing 1–5 of 10

Rows per page:

Market Current News

Modi urges both parties to honour border agreements

India PM Modi has urged both parties to adhere to existing border agreements, signalling a firm stance on maintaining established territorial frameworks.

12 Sept 2026

global

India, China issue joint statement after Xi-Modi meet

India and China issued a joint statement following a bilateral meeting between Xi Jinping and Narendra Modi, marking a significant diplomatic development between the two nations.

12 Sept 2026

global

Injecto Polymers IPO Day 1: Subscription at 0.06x

Injecto Polymers IPO sees modest demand on Day 1 with total subscription at 0.06x. Retail leads with 0.08x, while QIB remains flat. Issue closes on September 16.

11 Sept 2026

ipo

NSE IPO DRHP: ₹16,601 Cr Revenue, 99.79% Market Share

National Stock Exchange files DRHP for pure OFS of 12.64 crore shares. India's largest exchange reports FY26 revenue of ₹16,601 Cr and PAT of ₹10,302 Cr with dominant market share.

11 Sept 2026

ipo

Vinod Texworld IPO Day 3: Fully Subscribed

Vinod Texworld IPO crosses 1x mark on Day 3 with Retail driving demand. Total subscription stands at 1.16x as QIB remains flat. Check full subscription details.

11 Sept 2026

ipo

Showing 1–5 of 94221

Rows per page: